Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Laekna, Inc. ( (HK:2105) ) is now available.
Laekna, Inc. has announced the composition of its board of directors, which includes executive, non-executive, and independent non-executive directors. The board has three committees: Audit, Remuneration, and Nomination and Corporate Governance, with specific members assigned to each. This announcement highlights the company’s commitment to structured governance and strategic oversight, potentially impacting its operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:2105) stock is a Buy with a HK$24.16 price target. To see the full list of analyst forecasts on Laekna, Inc. stock, see the HK:2105 Stock Forecast page.
More about Laekna, Inc.
Laekna, Inc. is a company incorporated in the Cayman Islands, operating with limited liability. It is involved in the healthcare industry, focusing on pharmaceutical and biotechnology products and services.
Average Trading Volume: 4,141,452
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$6.59B
For detailed information about 2105 stock, go to TipRanks’ Stock Analysis page.